
USD
$0.00
(0.00%
)At Close (As of Dec 15, 2025)
$141.53M
Market Cap
-
P/E Ratio
-0.75
EPS
$2.92
52 Week High
$0.36
52 Week Low
HEALTHCARE
Sector
| Field | Value (USD) |
|---|---|
| Gross Profit | -$8.5M |
| Total Revenue | $0 |
| Cost Of Revenue | $8.5M |
| Costof Goods And Services Sold | $8.5M |
| Operating Income | -$116M |
| Selling General And Administrative | $29M |
| Research And Development | $87M |
| Operating Expenses | $107M |
| Investment Income Net | - |
| Net Interest Income | $4.7M |
| Interest Income | $4.7M |
| Interest Expense | - |
| Non Interest Income | - |
| Other Non Operating Income | - |
| Depreciation | - |
| Depreciation And Amortization | $8.5M |
| Income Before Tax | -$111M |
| Income Tax Expense | -$111M |
| Interest And Debt Expense | - |
| Net Income From Continuing Operations | -$111M |
| Comprehensive Income Net Of Tax | - |
| Ebit | -$111M |
| Ebitda | -$103M |
| Net Income | -$111M |
| Field | Value (USD) |
|---|---|
| Operating Cashflow | -$91M |
| Payments For Operating Activities | - |
| Proceeds From Operating Activities | - |
| Change In Operating Liabilities | - |
| Change In Operating Assets | - |
| Depreciation Depletion And Amortization | $8.5M |
| Capital Expenditures | $1M |
| Change In Receivables | - |
| Change In Inventory | - |
| Profit Loss | - |
| Cashflow From Investment | $1.1M |
| Cashflow From Financing | $48M |
| Proceeds From Repayments Of Short Term Debt | - |
| Payments For Repurchase Of Common Stock | - |
| Payments For Repurchase Of Equity | - |
| Payments For Repurchase Of Preferred Stock | - |
| Dividend Payout | - |
| Dividend Payout Common Stock | - |
| Dividend Payout Preferred Stock | - |
| Proceeds From Issuance Of Common Stock | - |
| Proceeds From Issuance Of Long Term Debt And Capital Securities Net | - |
| Proceeds From Issuance Of Preferred Stock | - |
| Proceeds From Repurchase Of Equity | - |
| Proceeds From Sale Of Treasury Stock | - |
| Change In Cash And Cash Equivalents | - |
| Change In Exchange Rate | - |
| Net Income | -$111M |
| Field | Value (USD) |
|---|---|
| Gross Profit | -$8.5M |
| Total Revenue | $0 |
| Cost Of Revenue | $8.5M |
| Costof Goods And Services Sold | $8.5M |
| Operating Income | -$116M |
| Selling General And Administrative | $29M |
| Research And Development | $87M |
| Operating Expenses | $107M |
| Investment Income Net | - |
| Net Interest Income | $4.7M |
| Interest Income | $4.7M |
| Interest Expense | - |
| Non Interest Income | - |
| Other Non Operating Income | - |
| Depreciation | - |
| Depreciation And Amortization | $8.5M |
| Income Before Tax | -$111M |
| Income Tax Expense | -$111M |
| Interest And Debt Expense | - |
| Net Income From Continuing Operations | -$111M |
| Comprehensive Income Net Of Tax | - |
| Ebit | -$111M |
| Ebitda | -$103M |
| Net Income | -$111M |
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
None